David Howton Biography and Net Worth

COO of Solid Biosciences

Mr. Howton is the Chief Operating Officer and leads corporate functions including program management, legal and human resources.

Mr. Howton has served as the Chief Operating Officer of Solid Biosciences since September 2023, having previously held the role of Chief Administrative Officer from December 2022. Mr. Howton served as the Chief Operating Officer and General Counsel of AavantiBio from March 2021 to December 2022.

From November 2012 to December 2020, Mr. Howton served as Executive Vice President, General Counsel and Corporate Secretary at Sarepta Therapeutics, Inc., or Sarepta, a precision genetic medicine company. Prior to joining Sarepta, Mr. Howton served as the Senior Vice President and Chief Legal Officer and Chief Compliance Officer at Vertex Pharmaceuticals. Prior to Vertex, Mr. Howton served in multiple legal roles at Genentech, Inc., a biotechnology company. Mr. Howton has served on the board of Make-A-Wish® Massachusetts and Rhode Island since March 2021.

Mr. Howton received a Bachelor of Arts in Political Science from Yale University and a Juris Doctor from Northwestern University School of Law.

What is David T. Howton's net worth?: The estimated net worth of David T. Howton is at least $194.82 thousand as of December 3rd, 2025. Mr. Howton owns 32,908 shares of Solid Biosciences stock worth more than $194,815 as of December 4th. This net worth evaluation does not reflect any other assets that Mr. Howton may own. Additionally, Mr. Howton receives an annual salary of $648,880.00 as COO at Solid Biosciences. Learn More about David T. Howton's net worth.
How old is David T. Howton?: Mr. Howton is currently 52 years old. There are 7 older executives and no younger executives at Solid Biosciences. The oldest executive at Solid Biosciences is Mr. Ian F. Smith A.C.A., C.P.A., Executive Chair, who is 58 years old. Learn More on David T. Howton's age.
What is David T. Howton's salary?: As the COO of Solid Biosciences Inc., Mr. Howton earns $648,880.00 per year. There are 2 executives that earn more than Mr. Howton. The highest earning executive at Solid Biosciences is Mr. Alexander G. Cumbo, President, CEO & Director, who commands a salary of $918,550.00 per year. Learn More on David T. Howton's salary.
How do I contact David T. Howton?: The corporate mailing address for Mr. Howton and other Solid Biosciences executives is 141 PORTLAND STREET FIFTH FLOOR, CAMBRIDGE MA, 02139. Solid Biosciences can also be reached via phone at (617) 337-4680 and via email at [email protected]. Learn More on David T. Howton's contact information.
Has David T. Howton been buying or selling shares of Solid Biosciences?: Over the course of the past ninety days, David T. Howton has sold $25,202.52 in shares of Solid Biosciences stock. Most recently, David T. Howton sold 4,932 shares of the business's stock in a transaction on Wednesday, December 3rd. The shares were sold at an average price of $5.11, for a transaction totalling $25,202.52. Following the completion of the sale, the chief operating officer now directly owns 32,908 shares of the company's stock, valued at $168,159.88. Learn More on David T. Howton's trading history.
Who are Solid Biosciences' active insiders?: Solid Biosciences' insider roster includes Gabriel Brooks (Chief Medical Officer), Alexander Cumbo (President & CEO), Ilan Ganot (Co-Founder and Strategic Advisor to the CEO), Jessie Hanrahan (Chief Regulatory & Preclinical Operations Officer), Paul Herzich (CTO), David Howton (COO), Clare Kahn (Director), Carl Morris (Insider), and Kevin Tan (CFO). Learn More on Solid Biosciences' active insiders.
Are insiders buying or selling shares of Solid Biosciences?: During the last twelve months, Solid Biosciences insiders bought shares 1 times. They purchased a total of 1,860 shares worth more than $9,932.40. During the last twelve months, insiders at the sold shares 8 times. They sold a total of 31,092 shares worth more than $155,239.01. The most recent insider tranaction occured on December, 3rd when COO David T Howton sold 4,932 shares worth more than $25,202.52. Insiders at Solid Biosciences own 1.9% of the company. Learn More about insider trades at Solid Biosciences.
Information on this page was last updated on 12/3/2025.

David T. Howton Insider Trading History at Solid Biosciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/3/2025	Sell	4,932	$5.11	$25,202.52	32,908
12/3/2024	Sell	5,072	$5.60	$28,403.20	15,663
12/4/2023	Sell	5,367	$2.78	$14,920.26	7,684

David T. Howton Buying and Selling Activity at Solid Biosciences

Solid Biosciences Company Overview

Solid Biosciences Inc., a life science company, develops therapies for neuromuscular and cardiac diseases in the United States. The company's lead product candidate is SGT-003, a gene transfer candidate for the treatment of Duchenne muscular dystrophy; and SGT-501 to treat Catecholaminergic polymorphic ventricular tachycardia. It is also developing AVB-401 for the treatment of BAG3-mediated dilated cardiomyopathy; SGT-601 to treat a rare cardiac disease characterized by mutations in the gene that codes for cardiac troponin T protein, which helps coordinate contraction of the heart muscle; SGT-701 for treatment of rare inherited disease characterized by mutations in the RBM20 gene, a cardiac splicing factor that regulates alternative splicing, and codes for RNA binding motif protein 20; and AVB-202-TT to treat Friedreich's ataxia, as well as other drugs for the treatment of cardiac and other diseases. In addition, the company is involved in developing platform technologies, including capsid libraries and dual gene expression, a technology for packaging multiple transgenes into one capsid. The company has collaboration and license agreement with Ultragenyx Pharmaceutical Inc. to develop and commercialize new gene therapies for Duchenne; and a license agreement with the University of Washington, University of Missouri, and University of Florida. Solid Biosciences Inc. was incorporated in 2013 and is headquartered in Charlestown, Massachusetts.

Today's Range

Now: $5.92

$5.36

$5.97

50 Day Range

MA: $5.34

$3.93

$6.40

2 Week Range

Now: $5.92

$2.41

$7.37

Volume

1,597,066 shs

Average Volume

1,045,629 shs

Market Capitalization

$461.23 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.97

David Howton Biography and Net Worth

What is David T. Howton's net worth?

How old is David T. Howton?

What is David T. Howton's salary?

How do I contact David T. Howton?

Has David T. Howton been buying or selling shares of Solid Biosciences?

Who are Solid Biosciences' active insiders?

Are insiders buying or selling shares of Solid Biosciences?